The International Society on Thrombosis and Haemostasis (ISTH) is excited to announce the launch of its new open access journal, Research and Practice in Thrombosis and Haemostasis (RPTH) (6-2017)
As part of its core mission, the ISTH is dedicated to transformative scientific discoveries and clinical practices, the development of young professionals and the education of physicians, scientists and allied health professionals wherever they may live. Today’s ever-evolving publishing landscape demands for increased global access and more opportunities to rapidly consume knowledge and scientific results. As we enter a new area of scientific discovery and knowledge dissemination, RPTH is an exciting medium for rigorous yet rapid peer review and immediate dissemination of research. As an open access and online-only publication, RPTH will serve as a catalyst for global discussion and connect scientists and clinicians with the non-scientist public to discuss the latest findings and research in the field.Complementing the Society’s flagship journal, the Journal of Thrombosis and Haemostasis (JTH), RPTH will provide an innovative new open access platform for science and discourse among researchers, clinicians, nurses, allied health professionals, and patients. Published in partnership with Wiley, RPTH is interested in basic, clinical, translational and population or public health research. Mary Cushman, M.D., M.Sc., professor of medicine at the Larner College of Medicine at the University of Vermont, and director of the thrombosis and hemostasis program at the University of Vermont Medical Center in the United States, will lead the launch of the journal as its inaugural Editor-in-Chief.
American Heart Month: Zakai Research Q&A on Populations Most at Risk for Vascular Disease (2-3-2017)
The following interview with Neil Zakai, M.D., M.Sc., associate professor of medicine at the Larner College of Medicine at the University of Vermont, originally appeared on the Facebook page of the Thrombosis and Haemostasis journal and focused on his research publication, titled “D-dimer and the Risk of Stroke and Coronary Heart Disease: The REasons for Geographic and Racial Differences in Stroke (REGARDS),” which was pre-published online in December 2016.
Tracy to Play Role in NIH Study of Molecular Changes during Physical Activity(12-13-2016)
The National Institutes of Health (NIH) Common Fund has announced the first awards for its Molecular Transducers of Physical Activity in Humans Program, which will allow researchers to develop a comprehensive map of the molecular changes that occur in response to physical activity and uncover findings that could lead to people engaging in more targeted and optimized types of activity.Nineteen grants totaling approximately $170 million through fiscal year 2022 (pending availability of funds) will support researchers across the country – including Russell Tracy, Ph.D., of the Larner College of Medicine at the University of Vermont.
Cushman Discusses Why Elite Athletes Can Get Abnormal Blood Clots (5-10-2016)
We keep hearing news stories about elite athletes developing abnormal blood clots. In recent sports news, we have heard about NBA and NHL players with clots. Mary Cushman, M.D., M.Sc., UVM professor of medicine and hematologist and medical director for the Thrombosis and Hemostasis Program at the UVM Medical Center, writes a blog about the issue.
Who is really at risk for blood clots? (3-27-2016)
In honor of DVT awareness month, Mary Cushman, M.D., M.Sc., UVM professor of medicine and hematologist and medical director for the Thrombosis and Hemostasis Program at the UVM Medical Center, breaks down the myths for the blog The Doctor Weighs In.
College Welcomes Jensen, Thanks Tracy, in Senior Research Dean Transition (2-05-2016)
New University of Vermont College of Medicine Senior Associate Dean for Research Gordon Jensen, M.D., Ph.D., was officially welcomed to the College at a special reception held February 4, 2016 that also honored the many contributions of Russell Tracy, Ph.D., professor of pathology, who served as interim senior associate dean for research from 2014 until Jensen’s arrival in January 2016.
Tracy Honored with 2015 Distinguished Scientist Award from American Heart Association (11-05-2015)
University of Vermont (UVM) College of Medicine Professor of Pathology and Laboratory Medicine Russell Tracy, Ph.D., will be awarded the Distinguished Scientist designation by the American Heart Association (AHA)/American Stroke Association (ASA) during the Opening Session at the AHA 2015 Scientific Sessions on November 8, 2015 in Orlando, Fla.
Unexpected Health Discovery Leads to Blood-Clotting Research Gift (8-13-2015)
Joe Golding, CEO of Advancement Resources, was giving a presentation to faculty and health care providers from the University of Vermont Medical Center, the UVM College of Medicine and the UVM College of Nursing and Health Sciences when Yael Friedman noticed something unusual. Friedman asked Mary Cushman, M.D. to take a look at Golding’s leg.
Olson Research Shows Life’s Simple 7 May Help Lower Risk for Venous Thrombosis (4-27-2015)
Life’s Simple 7, an assessment tool from the American Heart Association, has proven to be an effective way to track the population’s cardiovascular health in an effort to improve outcomes by 2020. A new study, published in the Journal of the American Heart Association, from a team led by UVM Postdoctoral Fellow Nels Olson, Ph.D. ’11, has shown that a favorable Life’s Simple 7 status also is related to decreased risk from another dangerous but less well-known threat: Venous thromboembolism (VTE).
UVM Lab Is Go-to for Genetic Specimens (3-12-2015)
Precision medicine found the limelight when President Obama unveiled a $215 million initiative to target its growth as part of his 2015 State of the Union Address in January, but for researchers both nationwide and at the University of Vermont, exploring how to best tailor medicine to individual needs has been the focus of their work for years. Whether it’s referred to as precision, personalized or genomic medicine, the goal is the same: to obtain individuals’ detailed genetic information so that both risk and treatment of disease can be dealt with at the most elemental level.
Cushman Blogs about Reducing Stroke and Cardiovascular Disease Risk (2-23-2015)
As the month of February and American Heart Month wrap up at the end of this week, it's important to focus on findings from University of Vermont and other research regarding how to reduce stroke and cardiovascular disease. Mary Cushman, M.D., M.Sc., UVM professor of medicine and hematologist and medical director for the Thrombosis and Hemostasis Program at the UVM Medical Center, recently posted a blog on the subject.
Tracy Coauthors Nature Study on Rare Genetic Mutations Associated with Heart Attack (2-04-2015)
New research findings indicate that LDL – the “bad” cholesterol – may have company as a major risk factor for heart attacks that occur at an early age. The new culprit: a mutation in VLDL – or very low-density lipoprotein – a group of triglyceride-rich lipoproteins. The study is published in the February 5, 2015 issue of Nature